TLOTX
Price
$9.16
Change
+$0.12 (+1.33%)
Updated
May 2 closing price
Net Assets
235.01M
VIVIX
Price
$65.79
Change
+$1.00 (+1.54%)
Updated
May 2 closing price
Net Assets
190.51B
Ad is loading...

TLOTX vs VIVIX

Header iconTLOTX vs VIVIX Comparison
Open Charts TLOTX vs VIVIXBanner chart's image
Transamerica Large Value Opps I3
Price$9.16
Change+$0.12 (+1.33%)
VolumeN/A
Net Assets235.01M
Vanguard Value Index I
Price$65.79
Change+$1.00 (+1.54%)
VolumeN/A
Net Assets190.51B
TLOTX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TLOTX vs. VIVIX commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLOTX is a Buy and VIVIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 191B vs. TLOTX (235M). VIVIX pays higher dividends than TLOTX: VIVIX (2.35) vs TLOTX (1.65). TLOTX was incepted earlier than VIVIX: TLOTX (8 years) vs VIVIX (27 years). TLOTX (0.50) is less costly to investors than VIVIX (0.04). TLOTX is a more actively managed with annual turnover of: 111.00 vs. VIVIX (9.00). TLOTX has a lower initial minimum investment than VIVIX: TLOTX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.67 vs. TLOTX (-9.25). VIVIX return over 5 years is better than : 76.44 vs. TLOTX (26.48).
TLOTXVIVIXTLOTX / VIVIX
Total Expense Ratio0.500.041,250%
Annual Report Gross Expense Ratio0.500.041,250%
Fund Existence8 years27 years-
Gain YTD-0.586-0.336174%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets235M191B0%
Annual Yield % from dividends1.652.3570%
Returns for 1 year-9.257.67-121%
Returns for 3 years-2.7719.05-15%
Returns for 5 years26.4876.4435%
Returns for 10 yearsN/A98.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEON0.500.06
+14.71%
AEON Biopharma
CASS41.600.30
+0.73%
Cass Information Systems
AVTE93.80N/A
N/A
Aerovate Therapeutics
INSM72.30-0.34
-0.47%
Insmed
CGEN1.48-0.04
-2.63%
Compugen Ltd